Versameb AG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2a Study To Evaluate VMB-100 In Females With Stress Urinary Incontinence (NCT06247241) | Versameb AG | 2025-09-01 |
Track Versameb AG automatically
Every clearance here is in the API, with alerts when new ones post.